Polycystic Ovarian Syndrome: Effect of Hormones, Associated Comorbidities and Recent Advances in Therapy
-
Published:2024-05-03
Issue:
Volume:
Page:1643-1654
-
ISSN:2456-2165
-
Container-title:International Journal of Innovative Science and Research Technology (IJISRT)
-
language:en
-
Short-container-title:International Journal of Innovative Science and Research Technology (IJISRT)
Author:
Raju M. Ganga,Archana B.,Reddy N.V.L.V Suvarchala,Manasa P.,Kaveri G.
Abstract
This study addresses the prevalent endocrine disorder, Polycystic Ovarian Syndrome (PCOS), affecting women of reproductive age. The research aims to explore the epidemiology, etiology, genetic factors, transmission patterns, environmental influences, hormonal imbalances, and comorbidities associated with PCOS. The methodology involves a comprehensive review of literature, including studies on PCOS prevalence, diagnostic criteria, phenotype classification, neuroendocrine links, genetic markers, environmental and lifestyle factors, heavy metal exposure, oxidative stress, follicular ER stress, hormonal imbalances, gut hormones, and adipose tissue dysfunction in PCOS. Results point to PCOS having a multigenetic basis, being transmitted across generations, and being influenced by environmental variables. Hormonal imbalances, including androgen excess, insulin resistance, and dysregulation of gonadotropin hormones, are significant in PCOS pathophysiology. The study also discusses the impact of PCOS on infertility, psychological stress, thyroid dysfunction, insulin resistance, dyslipidemia, diabetes,and obesity. The implications of this research highlight the need for a comprehensive strategy to managing PCOS, considering genetic predispositions, environmental exposures, lifestyle modifications, and hormonal imbalances. It also discussed alternative therapies. such as yoga, tai chi, qigong, acupuncture, and Chinese herbal medicine, and discusses the current treatment options for PCOS, including meditative stress reduction, melatonin, and cryptotanshinone.
Publisher
International Journal of Innovative Science and Research Technology
Reference42 articles.
1. Singh, S., Pal, N., Shubham, S., Sarma, D.K., Verma, V., Marotta, F. and Kumar, M, “Polycystic ovary syndrome: etiology, current management, and future therapeutics,” Journal of Clinical Medicine, vol.1 ,no . 2(4), pp.1454, 2023. 2. Zeng, L.H., Rana, S., Hussain, L., Asif, M., Imran, I. and Al-Joufi, F.A, “Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies,” Frontiers in Pharmacology, vol .13, pp.874914, 2022. 3. Escobar-Morreale, H.F, “Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment,” Nature Reviews Endocrinology, vol.14, no. 5, pp.270-284, 2018. 4. Jabeen, A., Yamini, V., Amberina, A.R., Eshwar, M.D., Vadakedath, S., Begum, G.S. and Kandi, V, “Polycystic ovarian syndrome: prevalence, predisposing factors, and awareness among adolescent and young girls of South India, ” Cureus, vol.14, no .8, 2022. 5. Daniele, S., Chelucci, E., Scarfò, G. and Artini, P.G, “Molecular Research on Polycystic Ovary Syndrome (PCOS),” Biomedicines, vol.11, no.5, pp.1358, 2023.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Overview of Lung Cancer;International Journal of Innovative Science and Research Technology (IJISRT);2024-05-07
|
|